<i>In vivo</i>, peritumoral administration of PPP/MTX-Mn markedly suppressed tumor growth in a melanoma-bearing mouse model, reduced the tumor burden, and significantly decreased Ki-67 expression. The gene discussed is MKI67; the disease is melanoma.